We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
This study aims to identify a nitroimidazo-oxazole lead molecule for the treatment of visceral leishmaniasis
This document contains the following information: Pre-judgment interest on debts and damages: item 4 of the eighth programme of law reform compound interest.
Guidance to help organisations choose a monitoring approach for stack emissions to air that meets Environment Agency and MCERTS requirements (formerly part of M2).
Government response to the report by the Advisory Council on the Misuse of Drugs on xylazine, medetomidine and detomidine.
Series of compound animal feed prices across Great Britain
The development of a risk-based approach to the regulation of volatile organic compounds (VOC) according to the propensity to produce ozone.
Article in 'Bioorganic and Medicinal Chemistry Letters'
Explains planning controls relating to the storage of hazardous substances in England and how to handle development proposals around hazardous establishments.
Labelling rules for businesses in Great Britain (England, Scotland and Wales) and retailers in Northern Ireland, for certain agri-food products moved under the Northern Ireland Retail Movement Scheme.
Guidance for those producing, processing, consuming, importing or exporting chemicals covered by the Chemical Weapons Convention (CWC)
A series of aminothiazoles were synthesized and screened for in vitro efficacy, solubility and microsomal stability
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (9 April 2024) approved the medicine fosdenopterin (Nulibry) to treat the genetic disease Molybdenum Cofactor Deficiency (MoCD) Type A
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).